Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recombinant allergens

R Valenta1, S Vrtala, S Laffer

  • 1Institutes of General and Experimental Pathology, University of Vienna, Austria.

Allergy
|August 5, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuronal response to high negative affective stimuli in major depressive disorder: An fMRI study.

Journal of affective disorders·2021
Same author

E-cadherin mediated cell-biomaterial interaction reduces migration of keratinocytes in-vitro.

Colloids and surfaces. B, Biointerfaces·2019
Same author

Self-consistent gradient flow for shape optimization.

Optimization methods & software·2017
Same author

IgE responses to exogenous and endogenous allergens in atopic dermatitis patients under long-term systemic cyclosporine A treatment.

Allergy·2015
Same author

NF-κB-dependent DNA damage-signaling differentially regulates DNA double-strand break repair mechanisms in immature and mature human hematopoietic cells.

Leukemia·2015
Same author

Control of proliferation and osteogenic differentiation of human dental-pulp-derived stem cells by distinct surface structures.

Acta biomaterialia·2013
Same journal

Decoding the "Metallic" Immune Imprint: Single-Cell Exposomics Reveals the Immune Imprint of Fire Smoke.

Allergy·2026
Same journal

Immunonutrition in Early Life: The Role of Complementary Feeding, Dietary Patterns, and Nutritional Exposures on the Health of Young Children-An EAACI Scoping Review.

Allergy·2026
Same journal

Detergent-Containing Toothpaste Decreases Esophageal Mucosal Impedance and Alters Salivary Properties in Humans.

Allergy·2026
Same journal

Global Variation in Timing of Allergenic Food Introduction for Food Allergy Prevention: An International Survey of Healthcare Professionals.

Allergy·2026
Same journal

Deficiency of Mitochondrial Fatty Acid Enzyme, CPT1A, Underlies Airway Epithelial Barrier Dysfunction in Severe Asthma.

Allergy·2026
Same journal

Surgical Management of Non-Allergic Rhinitis-An EAACI Task Force Position Paper.

Allergy·2026
See all related articles

Recombinant allergens, produced using DNA, are increasingly available for allergy research, diagnosis, and therapy. These biologically active molecules are crucial for understanding immune responses and developing improved allergy treatments.

Area of Science:

  • Biotechnology
  • Immunology
  • Molecular Biology

Background:

  • Recombinant allergens are produced in various hosts using complementary DNA (cDNA).
  • The availability of biologically active recombinant allergens is rapidly expanding.
  • These molecules are vital for research, diagnostics, and therapeutics.

Purpose of the Study:

  • To highlight the growing importance and applications of recombinant allergens.
  • To discuss their role in understanding T-cell and B-cell recognition.
  • To explore their potential in allergy diagnosis and immunotherapy.

Main Methods:

  • Expression of diverse recombinant allergens (plant, mite, mold, mammal, insect) in heterologous hosts like Escherichia coli.
  • Demonstration of immunologic equivalence with natural allergens.

Related Experiment Videos

  • Structural elucidation of several recombinant allergens.

    • Main Results:

    • Recombinant allergens are effective tools for studying allergen recognition and IgE regulation.
    • Many recombinant allergens are immunologically equivalent to their natural forms.
    • Structural data and cross-reactivity studies suggest a limited number of key epitopes are needed for diagnosis and immunotherapy.

    Conclusions:

    • Recombinant allergens are valuable for allergy research, diagnosis, and immunotherapy development.
    • Their use in diagnosis and immunotherapy is expanding.
    • Ongoing work aims to create safer recombinant allergen derivatives for improved treatments.